TOPICAL TREATMENT OF LOCALIZED SCLERODERMA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160120865A1
SERIAL NO

14897516

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are compositions and formulations for topical administration that contain a tyrosin kinase inhibitor, such as imatinib or nilotinib. The topical compositions or formulations are useful in treating scleroderma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PRECISION DERMATOLOGY INC400 HIGHLAND CORPORATE DRIVE CUMBERLAND RI 02864

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lafyatis, Robert Alan Arlington, US 1 0
Majhi, Pinaki Ranjan Sharon, US 5 139
Redmon, Martin P Oxford, US 19 366
Trumbore, Mark W Westford, US 33 731

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation